TÜBİTAK 1501, 1507 and PCT: What Investors Should Verify

What R&D support can demonstrate

TÜBİTAK describes 1501 as a program supporting project-based industrial R&D and innovation for eligible Turkish SMEs, with evaluation and periodic monitoring. The 1507 program is designed as an entry route for SME R&D capability. Support can indicate that a defined project passed an external process; it does not certify market demand or guarantee technical success.

What a PCT application means—and does not mean

WIPO explains that a PCT filing is an international patent application process that can support later national or regional protection decisions. The international phase includes formalities, search and a written opinion before national phases. A filing is not a granted patent. Investors should verify ownership, inventorship, priority, claim scope, search results, deadlines and freedom-to-operate work.

Build a traceable evidence chain

The useful diligence question is whether project objectives, technical records, prototypes, test results, IP claims and commercialization plans are connected. A strong data room shows the evolution of decisions, not only final presentations.

• Project agreements, scope, milestones and monitoring records.
• Controlled design files, test plans, results and deviations.
• IP assignments, applications, opinions, deadlines and strategy.

Vitruvex evidence should be read with claim discipline

Vitruvex presents V-UP(S) under TÜBİTAK 1501, V-NEURO under 1507 and its lumbar-support mechanism as a PCT application pathway. These are meaningful diligence inputs. They are presented as supported projects and an application—not as certified products, clinical outcomes or a granted international patent.